Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Self-controlled phase IV study of 1-dose versus 2-dose quadrivalent split influenza vaccine in children aged 3 to 8 years
CTR20220063Phase 4Active
- Sponsor
- Wuhan Institute of Biological Products
- Start
- Mar 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine in influenza, sponsored by Wuhan Institute of Biological Products. Started Mar 2022; status: active.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20220063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220063.